6 related news articles for Respiratory and Lung
-
Using our immune system to fight COVID-19
There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. … Read more
-
Melbourne Inflammation Symposium
More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.… Read more
-
Congratulations to our Three Minute Thesis Competition final winners
Congratulations to our PhD students who presented their exceptional research at this year’s Hudson Institute/SCS Three Minute Thesis (3MT) competition final on Wednesday, 4 July. The Three Minute Thesis (3MT™) is a national research communication competition that celebrates exciting research conducted by PhD research students. Students have three minutes to present a compelling oration on… Read more
-
High-dose steroids don’t prevent asthma flare-ups
High doses of glucocorticoids are not effective in preventing life-threatening asthma flare-ups, according to a landmark study published in The New England Journal of Medicine (NEJM). Glucocorticoids are anti-inflammatory medications used in many everyday prescription asthma puffers, such as turbuhalers or accuhalers. Hudson Institute research group head, Professor Phil Bardin was invited by the NEJM… Read more
-
$10 million in NHMRC funding for research including breast cancer, asthma and fetal hypoxia
Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).… Read more
-
WWI antiseptic could fight 21st century viral infections
Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.… Read more
